NCT02629783

Brief Summary

Some patients with shoulder pain have decreased body awareness (BA). To some degree, pain among these patients can be increased due to their lack in BA. Psychomotor therapy is thought to improve BA and thereby increase the effect of traditional therapy, such as physiotherapy and exercises. The aim of this study is therefore to investigate if psychomotor therapy, as a complimenting treatment to physiotherapy, decreases shoulder patients' function deficits and pain reported on PRO's, compared to physiotherapy alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2015

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 14, 2015

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

November 6, 2017

Status Verified

November 1, 2017

Enrollment Period

1.5 years

First QC Date

November 24, 2015

Last Update Submit

November 1, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient reported function and pain on the "Disability in the Arm, Shoulder and Hand (DASH) questionnaire"

    Patient reported generic shoulder outcome questionnaire (questions upon function and pain related limitations).

    Change from baseline DASH at 12 weeks

Secondary Outcomes (5)

  • Hospital Anxiety and Depression score (HAD)

    Change from baseline HAD at 12 weeks

  • Hospital Anxiety and Depression score (HAD)

    Change from baseline HAD at 24 weeks

  • Pain on the NRS Scale

    Change from baseline NRS at weeks 1-24

  • Multidimensional Assessment of Interoceptive Awareness (MAIA)

    Change from baseline MAIA at 12 weeks

  • Multidimensional Assessment of Interoceptive Awareness (MAIA)

    Change from baseline MAIA at 24 weeks

Other Outcomes (3)

  • Quality of life on "EQ-5D"

    Change from baseline EQ-5D at 12 weeks

  • Quality of life on "EQ-5D"

    Change from baseline EQ-5D at 24 weeks

  • Patient reported function and pain on the "Disability in the Arm, Shoulder and Hand (DASH) questionnaire"

    Change from baseline DASH at 24 weeks

Study Arms (2)

Physiotherapy + Corticosteroid injection + Psychomotor therapy

EXPERIMENTAL

Usual care + intervention

Other: Psychomotor therapyOther: PhysiotherapyDrug: corticosteroid injection

Physiotherapy + Corticosteroid injection

ACTIVE COMPARATOR

Usual care

Other: PhysiotherapyDrug: corticosteroid injection

Interventions

1 treatment of approximately 45 minutes the first 5 weeks after randomization. The treatment will focus on teaching the patients about body awareness and handling of there shoulder problems in daily living.

Physiotherapy + Corticosteroid injection + Psychomotor therapy

Patients are, in secondary care setting, given 3-5 basic physiotherapy exercises for there shoulder pain, targeting rotator cuff muscles and scapula thoracic muscles. Furthermore they are given advice on seeking further physiotherapy guidance in private setting.

Physiotherapy + Corticosteroid injectionPhysiotherapy + Corticosteroid injection + Psychomotor therapy

At baseline, patients with signs of inflammation in the subacromial bursa, can receive a ultrasound guided corticosteroid injection in the bursa

Physiotherapy + Corticosteroid injectionPhysiotherapy + Corticosteroid injection + Psychomotor therapy

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>three months of should pain
  • Disturbed sleep due to shoulder pain
  • VAS resting pain above 2 OR VAS activity pain above 5
  • MAIA score \<= 3
  • Read and understand Danish.

You may not qualify if:

  • Frozen shoulder
  • Glenohumeral (GH) arthritis
  • Rotator Cuff (RC) rupture
  • GH instability
  • Acromioclavicular joint arthritis
  • Operation in the shoulder joint within the last six months
  • Cervical problems
  • Psychiatric diagnosis
  • Alcohol or drug abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shoulder clinic, Orthopedic department, Hospital Lillebaelt - Vejle Hospital

Vejle, Jutland, 7000, Denmark

Location

Related Publications (1)

  • Ingwersen KG, Vobbe JW, Pedersen LL, Sorensen L, Wedderkopp N. Effect of Psychomotricity in Combination With 3 Months of Active Shoulder Exercises in Individuals With Chronic Shoulder Pain: Primary Results From an Investigator-Blinded, Randomized, Controlled Trial. Arch Phys Med Rehabil. 2019 Nov;100(11):2136-2143. doi: 10.1016/j.apmr.2019.05.032. Epub 2019 Jun 24.

MeSH Terms

Conditions

Shoulder Pain

Interventions

Physical Therapy ModalitiesAdrenal Cortex Hormones

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitationHormonesHormones, Hormone Substitutes, and Hormone Antagonists

Study Officials

  • Lilli Soerensen, MD

    Outpatient shoulder clinic, orthopaedic department at Hospital Lillebaelt - Vejle Hospital

    STUDY CHAIR
  • Kim G. Ingwersen, PhD.Fellow

    Rehabilitation department at Hospital Lillebaelt - Vejle Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2015

First Posted

December 14, 2015

Study Start

March 1, 2016

Primary Completion

September 1, 2017

Study Completion

September 1, 2017

Last Updated

November 6, 2017

Record last verified: 2017-11

Locations